Schwarzbach, M. H. M., Hinz, U., Dimitrakopoulou-Strauss, A., Willeke, F., Cardona, S., Mechtersheimer, G., . . . Büchler, M. W. (2005). Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue Sarcomas.
Citación estilo ChicagoSchwarzbach, Matthias H. M., et al. Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue Sarcomas. 2005.
Cita MLASchwarzbach, Matthias H. M., et al. Prognostic Significance of Preoperative [18-F] Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) Imaging in Patients With Resectable Soft Tissue Sarcomas. 2005.